Cipla announced its consolidated financial results for Q2 FY26, showing robust performance. Revenue from operations reached ₹7,589.44 crores. Net profit after tax stood at ₹1,353.37 crores. The company’s results reflect continued growth and operational efficiency. These figures highlight Cipla’s financial stability and market competitiveness. The board approved the results on October 30, 2025.
Financial Performance Highlights
Cipla’s consolidated revenue from operations for Q2 FY26 reached ₹7,589.44 crores, compared to ₹7,051.02 crores in Q2 FY25. The total income for the quarter was ₹7,858.39 crores. The company’s net profit after tax for the quarter stood at ₹1,353.37 crores. These results showcase a strong financial performance during the quarter.
Segment Revenue Analysis
Pharmaceuticals segment revenue was ₹7,291.43 crores, while the New Ventures segment contributed ₹350.68 crores. The total segment revenue reached ₹7,642.11 crores. After accounting for inter-segment revenue, the total revenue from operations was reported as ₹7,589.44 crores.
Expense Management
Total expenses for the quarter amounted to ₹6,004.86 crores. This included cost of materials consumed at ₹1,528.16 crores, employee benefits expense at ₹1,314.80 crores, and other expenses totaling ₹1,882.25 crores. Effective expense management contributed to overall profitability.
Earnings Per Share
The basic earnings per share stood at ₹16.73, and the diluted earnings per share was ₹16.72 for Q2 FY26. These figures reflect the company’s profitability distributed per equity share.
NPPA Matter Update
The company has received notices related to alleged overcharging, and after removing duplications, the total amount covered by these notices aggregates to ₹2,011 crores, comprising ₹863 crores principal and ₹1,148 crores interest. Cipla expects a favorable outcome and has made deposits without prejudice to its position.
Source: BSE
